These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21447974)

  • 1. Surveillance results of patients with stage I nonseminomatous germ cell testicular cancer.
    Keskin S; Ekenel M; Başaran M; Bavbek S
    Onkologie; 2011; 34(4):173-6. PubMed ID: 21447974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.
    Li X; Guo S; Wu Z; Dong P; Li Y; Zhang Z; Yao K; Han H; Qin Z; Zhou F; Liu Z
    World J Urol; 2015 Sep; 33(9):1351-7. PubMed ID: 25471669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
    Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
    Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testicular germ cell tumors, the state of diagnostics and staging in Saint-Petersburg].
    Nosov AK; Gafton GI; Meraboshvili VM; Mamizhev ÉM; Vorob'ev AV; Petrov SB
    Vopr Onkol; 2012; 58(2):238-42. PubMed ID: 22774531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal lymphadenectomy remains the treatment of choice in nonseminomatous germ cell tumors.
    Graham SD
    Semin Urol; 1993 May; 11(2):85-91. PubMed ID: 8395700
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSGCT).
    Sogani PC; Fair WR
    Semin Urol; 1988 Feb; 6(1):53-6. PubMed ID: 2838876
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
    Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
    BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance in patients with stage I nonseminomatous testicular tumors.
    Litwin MS; Richie JP
    Surg Annu; 1994; 26():89-99. PubMed ID: 8303525
    [No Abstract]   [Full Text] [Related]  

  • 12. Appropriateness of testicular cancer management: a population-based cohort study.
    Cheung WY; Demers A; Hossain D; Owen T; Ahmed S; Czaykowski PM
    Can J Urol; 2007 Jun; 14(3):3542-50. PubMed ID: 17594744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
    Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
    J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for clinical stage I nonseminomatous testis carcinoma: rationale and results.
    Stephenson RA
    Urol Int; 1991; 46(3):290-3. PubMed ID: 1656576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of the testis: a new paradigm.
    Einhorn LH
    Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
    [No Abstract]   [Full Text] [Related]  

  • 18. Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.
    Boyer MJ; Cox K; Tattersall MH; Findlay MP; Grygiel J; Rogers J
    Urology; 1997 Oct; 50(4):588-92. PubMed ID: 9338737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
    Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
    J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.